1895895-38-1 (CHZ868,CHZ868)

JAK2抑制剂(CHZ868);化合物CHZ868;

CHZ868;CHZ-868;CHZ 868; CHZ-868;Acetamide, N-[4-[[2-[(2,4-difluorophenyl)amino]-1,4-dimethyl-1H-benzimidazol-5-yl]oxy]-2-pyridinyl]-;N-[4-({2-[(2,4-difluorophenyl)amino]-1,4-dimethyl-1,3-benzodiazol-5-yl}oxy)pyridin-2-yl]acetamide;Q27162807;N-(4-((2-(2,4-difluoroanilino)-1,4-dimethyl-1H-benzimidazol-5-yl)oxy)pyridin-2-yl)acetamide;BCP19574;CHZ-868;CHZ 868;N-[4-[2-(2,4-difluoroanilino)-1,4-dimethylbenzimidazol-5-yl]oxypyridin-2-yl]acetamide;1895895-38-1;DA-51889;SCHEMBL20548035;AKOS032960476;N-[4-[2-[[2,4-bis(fluoranyl)phenyl]amino]-1,4-dimethyl-benzimidazol-5-yl]oxypyridin-2-yl]ethanamide;AC-33597;CS-6363;N-(4-{[2-(2,4-difluoroanilino)-1,4-dimethyl-1H-benzimidazol-5-yl]oxy}pyridin-2-yl)acetamide;N-(4-(2-((2,4-bis(fluoranyl)phenyl)amino)-1,4-dimethyl-benzimidazol-5-yl)oxypyridin-2-yl)ethanamide;HY-18960;CHEBI:90828;MS-27432;EX-A1610;VAD89538;

MFCD30533612

KQQLBXFPTDVFAJ-UHFFFAOYSA-N

InChI=1S/C22H19F2N5O2/c1-12-19(31-15-8-9-25-20(11-15)26-13(2)30)7-6-18-21(12)28-22(29(18)3)27-17-5-4-14(23)10-16(17)24/h4-11H,1-3H3,(H,27,28)(H,25,26,30)

CC(NC1=CC(OC2=CC=C(N(C)C(NC3=CC=C(F)C=C3F)=N4)C4=C2C)=CC=N1)=O